Of note, neither single nor double depletion of HSPA1 and HSPA2 sensitized NSCLC cells to anticancer drugs used in this study (Figs 2G–K and 3E,F, S1G–K). This evidence concerns the gene HSPA1B and non-small cell lung carcinoma.